| Previous close | 40.77 |
| Open | 40.88 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 40.88 - 40.88 |
| 52-week range | 34.46 - 41.19 |
| Volume | |
| Avg. volume | 4,975 |
| Market cap | 47.905M |
| Beta (5Y monthly) | 1.46 |
| PE ratio (TTM) | 0.08 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GuruFocus.com
Third Avenue Management Boosts Stake in Lazard Inc, Highlighting Strategic Portfolio Adjustments
Insight into the First Quarter Moves of 2024 by Third Avenue Management (Trades, Portfolio)
- Zacks
Lazard's (LAZ) April AUM Declines 3.8% on Weaker Markets
Lazard's (LAZ) preliminary AUM balance for April 2024 declines 3.8% on a sequential basis due to the impact of negative markets.
- Reuters
Lazard hires veteran healthcare dealmaker Colocci as vice chairman
Investment bank Lazard Ltd has appointed veteran healthcare dealmaker Michele Colocci as vice chairman and managing director, aiming to boost the growth of its healthcare advisory, according to a company announcement. Colocci, former chairman of mergers and acquisitions at Morgan Stanley, where he also held positions as global co-head of healthcare investment banking and deputy head of investment banking for Europe, is set to join the firm in June. In his new role, Colocci will be part of Lazard's healthcare franchise, led by David Gluckman and overseen in Europe by Jean-Louis Girodolle and Cyrus Kapadia.
